mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.5 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.5 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.6 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |